📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. (2024)

First Author: White CW

Attributed to: Exploiting a novel molecular toolkit to explore cell type specific adenosine receptor pharmacology and regulation at endogenous levels of expression. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scisignal.abl3758

PubMed Identifier: 38502733

Publication URI: http://europepmc.org/abstract/MED/38502733

Type: Journal Article/Review

Volume: 17

Parent Publication: Science signaling

Issue: 828

ISSN: 1945-0877